CTIS.eu › Cities › France › Marseille
Marseille
France
1,485 total trials
664 recruiting
Filter these 1,485 trials by phase, condition, sponsor and more.
Open in Search →
2024-520107-12-00
5
2025-09-03
Hidradenitis Suppurativa // Prurigo Nodularis // Vitiligo
2022-501866-22-00
9
2025-08-26
Acute Lymphoblastic Leukemia, in Relapse
Lymphoblastic Lymphoma (Precu
2022-502910-10-00
7
2025-08-11
Propionic Acidemia
2024-517589-41-00
1
2025-08-04
Advanced solid tumors
2025-520557-36-00
1
2025-07-24
Advanced Solid Tumors
2024-516616-24-00
5
2025-07-23
Acromegaly
2024-517968-36-00
5
2025-07-08
non-small cell lung cancer
2024-518973-32-00
5
2025-07-03
Chronic Graft-Versus-Host Disease
2024-512360-55-00
4
2025-06-30
Unresectable locally recurrent or metastatic hormone receptor (HR)-pos
2024-517032-22-00
5
2025-06-10
Immune system diseases.
2024-519128-26-00
4
2025-05-22
Non-foveal geographic atrophy secondary to non-neovascular age-related
2024-514239-21-00
3
2025-05-21
Spinal Muscular Atrophy
2024-515459-39-00
7
2025-05-08
Advanced or Metastatic Squamous Solid Tumors
2023-507936-20-00
5
2025-05-05
Acute myeloid leukemia
2024-511239-91-00
4
2025-05-05
Resectable Stage I-III Non-Small Cell Lung Cancer (NSCLC)
2024-514459-14-00
4
2025-04-22
Non-Small Cell Lung Cancer
2024-512659-19-00
10
2025-03-31
Advanced Melanoma
2024-515506-11-00
4
2025-03-24
Urothelial Carcinoma
2023-506537-29-00
5
2025-02-24
Haemophilia A
2024-515702-63-00
5
2025-02-20
Moderate-to-Severe Active Thyroid Eye Disease
2024-516869-36-00
1
2025-02-17
Relapsed or refractory B-cell malignancies: chronic lymphocytic leukem
2024-516339-28-00
4
2025-02-10
EGFR inhibitor-induced folliculitis
2024-511457-22-00
3
2025-01-30
Advanced Hematologic Malignancies
2024-513077-48-00
5
2024-12-19
O6-methylguanine methyltransferase (MGMT) unmethylated glioblastoma
Showing 193–216 of 1,485 trials